Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 2/20 | 0.56 |
| ▸ | BCHE | P06276 | 4/20 | 0.54 |
| ▸ | SLC2A1 | P11166 | 4/20 | 0.52 |
| ▸ | SLC2A4 | P14672 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.50 |
| ▸ | PTGES | O14684 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | LTC4S | Q16873 | 1/20 | 0.49 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1123268 | 0.93 | BCHE (0.56) | FFAR1BCHEALOX5MEN1KMT2A | |
| SCHEMBL1123043 | 0.91 | BCHE (0.52) | FFAR1BCHESLC2A1SLC2A4ALOX5 | |
| SCHEMBL1122608 | 0.90 | FFAR1 (0.59) | FFAR1BCHESLC2A1ALOX5PTGES | |
| SCHEMBL1123013 | 0.89 | FFAR1 (0.58) | FFAR1SLC2A1SLC2A4ALOX5PTGES | |
| SCHEMBL1123406 | 0.87 | NR4A2 (0.56) | FFAR1SLC2A1SLC2A4ALOX5PTGES | |
| SCHEMBL1123059 | 0.85 | SMPD1 (0.54) | BCHESLC2A1SLC2A4PTGESKMT2A | |
| SCHEMBL1122938 | 0.84 | BCHE (0.55) | FFAR1BCHEPTGESKMT2ASMPD1 | |
| SCHEMBL1123118 | 0.84 | KMT2A (0.58) | FFAR1SLC2A1SLC2A4PTGESKMT2A | |
| SCHEMBL1123224 | 0.83 | BCHE (0.53) | BCHEALOX5MEN1KMT2A | |
| SCHEMBL1123174 | 0.82 | NR4A2 (0.59) | FFAR1BCHESLC2A1SLC2A4ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1644321-B1 | NEW BENZAMIDES AS PPATY MODULATORS | S A L V A T LAB SA (ES) | 2011-02-09 | — | — | EP | claimed |
| US-20060160894-A1 | Benzamides as ppar modulators | LABORATORIOS S.A.L.V.A.T.,S.A. (ES) | 2006-07-20 | — | — | US | claimed |
| EP-1644321-A2 | NEW BENZAMIDES AS PPATY MODULATORS | LABORATORIOS S.A.L.V.A.T., S.A. (ES) | 2006-04-12 | — | — | EP | claimed |
| WO-2004110983-A2 | NEW BENZAMIDES AS PPARϒ MODULATORS | LABORATORIOS S.A.L.V.A.T., S.A. (ES) | 2004-12-23 | — | — | WO | claimed |
| EP-1644321-B1 | NEW BENZAMIDES AS PPATY MODULATORS | S A L V A T LAB SA (ES) | 2011-02-09 | — | — | EP | disclosed |
| US-20060160894-A1 | Benzamides as ppar modulators | LABORATORIOS S.A.L.V.A.T.,S.A. (ES) | 2006-07-20 | — | — | US | disclosed |
| EP-1644321-A2 | NEW BENZAMIDES AS PPATY MODULATORS | LABORATORIOS S.A.L.V.A.T., S.A. (ES) | 2006-04-12 | — | — | EP | disclosed |
| WO-2004110983-A2 | NEW BENZAMIDES AS PPARϒ MODULATORS | LABORATORIOS S.A.L.V.A.T., S.A. (ES) | 2004-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | PPARD, PPARA, PPARG | FFAR1 32/4885BCHE 520/4885SLC2A1 2494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.